Leaderboards/dermatological and skeletal disorders

dermatological and skeletal disorders

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Heonjong Han
Orion Corporation (United Kingdom)
99
2
Wei Song
Qingdao University
80
3
Madjer Hatia
Administração Regional de Saúde de Lisboa e Vale do Tejo
70
4
Laura Llansó
Universitat Autònoma de Barcelona
50
5
Lourdes Cumandá Carrera-Beltrán
Escuela Superior Politécnica del Chimborazo
30
6
Antonio J. Signes‐Pastor
Universitat de Miguel Hernández d'Elx
20

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Isha Duggal
All India Institute of Medical Sciences
99
2
M. Rato
Hospital de São João
90
3
Giulia Pascolini
Istituto Dermopatico dell'Immacolata
80
4
Kendall C. Shultes
VA Tennessee Valley Healthcare System
70
5
M Mokhtar
Ain Shams University
60
6
Frederico Moeda
Administração Regional de Saúde de Lisboa e Vale do Tejo
60
7
ALTAIB MOHAMMED
Faculty of Public Health
50
8
Dinkar Yadav
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences
40
9
Kugili Sathanantham
University of Liverpool
30
10
C Povýšil
Charles University
20

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Michael J. Econs
Indiana University School of Medicine
99
2
Jordi Surrallés
Universitat Autònoma de Barcelona
90
3
Hane Lee
Orion Corporation (United Kingdom)
90
4
Ian P. Wicks
Walter and Eliza Hall Institute of Medical Research
80
5
Pervin Dinçer
Hacettepe University
70
6
Tomoo Ogi
Nagasaki University
60
7
Eric Low
Myeloma UK
50
8
S. Ignacimuthu
Creighton University
40
9
Montse Olivé
Universitat Autònoma de Barcelona
40
10
William Martel
Tufts University
30

All-Time Leaders Papers

1
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Journal of Clinical Investigation|2007
476 cit.
2
Endogenous aldehyde-induced DNA–protein crosslinks are resolved by transcription-coupled repair
Nature Cell Biology|2024
56 cit.
3
Therapeutic Effects of a <scp>TANK</scp>‐Binding Kinase 1 Inhibitor in Germinal Center–Driven Collagen‐Induced Arthritis
Arthritis & Rheumatology|2018
24 cit.
4
Clinical consequences of BRCA2 hypomorphism
npj Breast Cancer|2021
12 cit.
5
Deep intronic founder mutations identified in the <i>ERCC4</i> / <i>XPF</i> gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum
Proceedings of the National Academy of Sciences|2023
12 cit.
6
TFIIH-p52ΔC defines a ninth xeroderma pigmentosum complementation–group XP-J and restores TFIIH stability to p8-defective trichothiodystrophy
Journal of Clinical Investigation|2025
2 cit.
7
Hydroxychloroquine impairs mTORC1-dependent cholesterol biosynthesis and sensitizes retinal pigment epithelial cells to UV-induced cell death.
Research Square|2022
0 cit.
8
Assessment of myogenic potency in patient-derived fibroblasts with c.1289-2A&gt;G Desmin mutation
Turkish Journal of Biochemistry|2024
0 cit.

Reagents for dermatological and skeletal disorders

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

DyLight® 554 Phalloidin

#13054$509
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

Phospho-NF-kappaB p65 (Ser536) (93H1) Rabbit Monoclonal Antibody (APC Conjugate)

#31553$493
View Evidence →Cell Signaling Technology

PTEN (D4.3) Rabbit Monoclonal Antibody (Sepharose Bead Conjugate)

#4326$465
View Evidence →Cell Signaling Technology

P2X7 Receptor (E1E8T) Rabbit Monoclonal Antibody

#13809$157
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

MAP7 Antibody

#88646$317
View Evidence →New England Biolabs

BbsI-HF®

#R3539S$66
View Evidence →Cell Signaling Technology

Annexin A2 (D11G2) Rabbit Monoclonal Antibody

#8235$161
View Evidence →